ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s share price traded down 7.4% during mid-day trading on Tuesday . The stock traded as low as $0.39 and last traded at $0.41. 213,862 shares were traded during mid-day trading, an increase of 952% from the average session volume of 20,327 shares. The stock had previously closed at $0.44.
ImmunoPrecise Antibodies Price Performance
The stock’s 50-day moving average is $0.56 and its two-hundred day moving average is $0.82.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
See Also
- Five stocks we like better than ImmunoPrecise Antibodies
- With Risk Tolerance, One Size Does Not Fit All
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- Consumer Staples Stocks, Explained
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- What is the Nasdaq? Complete Overview with History
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
